EXERCISE PROGRAM FOR THE PREVENTION OF OSTEOPOROTIC FRACTURE
With
Belinda Beck,
Professor of Exercise Science,
Griffith University &
Owner and Director, The Bone Clinic &
Member of Medical and Scientific Advisory Committee
Healthy Bones Australia (formerly Osteoporosis Australia)
RESEARCHER PROFILE
Filmed in Southport, Queensland, Australia | May 2025
Dr Beck is an international leader in the effects of mechanical loading on bone health. Dr Beck graduated from The University of Queensland (BHMS[Ed]) and the University of Oregon (MSc and PhD) and completed a postdoctoral research fellowship in the Stanford University School of Medicine (California, USA.) She is a Professor of Exercise Science at Griffith University Gold Coast campus, where she has led the Bone Densitometry Research Laboratory since 2004.
Dr Beck has been awarded $7.6M in research grant funding to work on both animal and human models, from basic to clinical research. She has extensive experience leading clinical trials and the development of methodologies in musculoskeletal measurement. Her particular focuses have been exercise interventions across the lifespan for bone health, and bone stress injuries in athlete and military populations. In recent years she developed the first effective exercise program for the prevention of osteoporotic fracture.
The impact and significance of her work are reflected in 108 peer-reviewed journal articles (80% Q1 journals, 83.3% in top 25% journals by CiteScore), 7 chapters and 16 consumer publications in her field. Over 35% of her publications are in the top 10% most viewed publications worldwide (SciVal).
She has supervised 11 PhD, 5 Masters and 13 Honours students to completion and is currently supervising 2 PhD students, 1 Masters and 1 Honours student, along with three research associates (fellows and assistants). She has delivered 40 invited presentations worldwide (e.g., London, Italy, France, Germany, and the USA) and 57 nationally. She is a Board member of the International Osteoporosis Foundation Capture the Fracture programme, Sports Medicine Australia, the Australian and New Zealand Bone and Mineral Society and a Fellow of the American Society of Bone and Mineral Research, the American College of Sports Medicine, Sports Medicine Australia and Exercise Sports Science Australia.
Dr Beck’s research impact stems from the results of successful and innovative clinical trials and methodological studies that have changed practice in the fields of osteoporosis and military medicine and research practice. The implementation of her research outcomes in the real world seek to make genuine and significant differences to the quality and productivity of people.
Source: Adapted from supplied copy
-
Exercise therapy for metabolic dysfunction-associated steatotic liver disease
Dr Shelley Keating is a Senior Lecturer in Clinical Exercise Physiology and Accredited Exercise Physiologist from the School of Human Movement and Nutrition Sciences at the University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating’s research centres on the utility of exercise as a therapy for obesity and related cardiometabolic conditions, notably metabolic dysfunction-associated steatotic liver disease (MASLD).
-
Health and economic burden of interstitial lung diseases
Dr Cox’s main research interests focus on respiratory diseases and primarily on the economic burden and economic evaluation of interventions and treatments for their management. She earned her PhD from the University of Tasmania where her doctoral research examined the health and economic burden of idiopathic pulmonary fibrosis (IPF) in Australia, one component of the NHMRC Centre for Research Excellence for Pulmonary Fibrosis, a national project implemented alongside the Australian IPF Registry and the Lung Foundation Australia. This research provided the first epidemiological profile and first costing estimates of the economic burden of the disease in Australia, providing essential evidence for health service reimbursement policies.
-
Discovery of RANK Ligand’s role in bone metabolism and the immune system to treat osteoporosis
Emeritus Professor Jack Martin’s research began a discovery cascade that led to the identification of a new protein and the development of a novel and effective drug therapy that is now used worldwide to treat osteoporosis, cancer and other diseases.
